
Antiulcer Agent 1
CAS No. 76001-09-7
Antiulcer Agent 1( —— )
Catalog No. M26026 CAS No. 76001-09-7
Antiulcer Agent 1 is a 2-(3,4-dimethoxyphenyl)ethylamine derivative for oral administration.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
![]() ![]() |
10MG | 581 | Get Quote |
![]() ![]() |
25MG | 888 | Get Quote |
![]() ![]() |
50MG | 1242 | Get Quote |
![]() ![]() |
100MG | 1674 | Get Quote |
![]() ![]() |
500MG | 3348 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAntiulcer Agent 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntiulcer Agent 1 is a 2-(3,4-dimethoxyphenyl)ethylamine derivative for oral administration.
-
DescriptionAntiulcer Agent 1 is a 2-(3,4-dimethoxyphenyl)ethylamine derivative for oral administration.(In Vivo):The serum levels of the compounds in rats are almost related to the dissolution rates in the JP 1st disintegration medium from the discs. The serum level of alpha-anhydrate is the lowest.
-
In Vitro——
-
In VivoThe hydrochloride form shows incompatibility with the excipients used for oral dosage forms. There are several crystal forms of the free base, namely, alpha-anhydrate, beta-anhydrate, monohydrate, and trihydrate. The trihydrate form is unstable. The degree of crystallinity of the beta-anhydrate form is difficult to control. The monohydrate form is difficult to manufacture with constant quality. The serum levels of the compounds in rats are almost related to the dissolution rates in the JP 1st disintegration medium from the discs. The serum level of alpha-anhydrate is the lowest.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76001-09-7
-
Formula Weight357.41
-
Molecular FormulaC19H23N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(CCNC(=O)CNc2cccc(c2)C(N)=O)cc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee DH, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 2016 Sep 12;99:520-532.
molnova catalog



related products
-
Olsalazine
Olsalazine, an anti-inflammatory drug, is used in the treatment of inflammatory bowel disease. It is also a novel DNA hypomethylating agent.
-
Ganoderic acid M
Ganoderic acid Me and/or ganoderic acid T have obvious action for inhibiting human tumor cell growth or proliferation, at the same time its toxicity for normal cells is low.
-
CADD522
CADD522 is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA binding with an IC50 of 10 nM, with antitumor activityCADD522 is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA binding( IC50 of 10 nM), has antitumor activity.